Book excerpt: The Neurovascular Intervention Market experienced dramatic changes in 2010. In June Covidien entered the market by acquiring ev3, the second leading player, for $2.6 billion, in July DePuy (Johnson & Johnson) acquired Micrus Endovascular for $480 million and moved to second place and in October Stryker acquired Boston Scientific's neurovascular business unit for $1.5 billion and became the new market leader. These new players, together with Terumo, are changing the neurovascular strategic landscape, the rules of the game, critical success factors as well as valuations for new technologies and innovative start-ups. How does the new neurovascular landscape look like? How have market shares been redistributed? What are current growth trends? How will the market evolve in the near future? Neurovascular Intervention Market Report attempts to answer these questions and many more. Neurovascular Intervention Market Report analyzes revenue and growth trends for the entire sector with special emphasis on embolic coils, intracranial stents, liquid embolics and thrombectomy devices. The report also segments the market based on disease areas with special emphasis on cerebral aneurysm and both acute and chronic cerebral ischemia. Neurovascular Intervention Market Report examines Leading companies technologies, product offerings, market shares and strategic positions, uncovers areas with maturing trends as well as areas with high growth potential and provides an updated forecast to 2015.